Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Female × Bupivacaine × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Vesico-Ureteral Reflux 1 Ureteral Neoplasms 1 Pancreatic Neoplasms 1 Nephrolithiasis 1 Laparoscopic Surgery 1 Kidney Neoplasms 1 Gynecologic Surgical Procedures 1 Duodenal Neoplasms 1 Digestive System Diseases 1 Breast Cancer Female 1

Interventions

exemestane 1 abemaciclib 1 Tamoxifen 1 Mastectomy 1 Letrozole 1 Dexmedetomidine 1 Bupivacaine 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03063073 2026-02-12

pec's

South Egypt Cancer Institute

Phase 3 Completed

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡